nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCB11—Tamoxifen—pancreatic cancer	0.0527	0.0748	CbGbCtD
Glyburide—SLCO2B1—Erlotinib—pancreatic cancer	0.0518	0.0736	CbGbCtD
Glyburide—ABCC3—Fluorouracil—pancreatic cancer	0.0449	0.0638	CbGbCtD
Glyburide—SLC22A7—Fluorouracil—pancreatic cancer	0.0351	0.0499	CbGbCtD
Glyburide—ABCC1—Epirubicin—pancreatic cancer	0.0296	0.0419	CbGbCtD
Glyburide—ABCC1—Irinotecan—pancreatic cancer	0.0287	0.0408	CbGbCtD
Glyburide—ABCC2—Tamoxifen—pancreatic cancer	0.0277	0.0393	CbGbCtD
Glyburide—SLC22A7—Docetaxel—pancreatic cancer	0.0268	0.0381	CbGbCtD
Glyburide—ABCC3—Doxorubicin—pancreatic cancer	0.0256	0.0363	CbGbCtD
Glyburide—ABCG2—Tamoxifen—pancreatic cancer	0.0251	0.0356	CbGbCtD
Glyburide—ABCB11—Doxorubicin—pancreatic cancer	0.0221	0.0314	CbGbCtD
Glyburide—CFTR—ventral pancreatic duct—pancreatic cancer	0.0216	0.232	CbGeAlD
Glyburide—ABCG2—Erlotinib—pancreatic cancer	0.0213	0.0302	CbGbCtD
Glyburide—ABCC2—Irinotecan—pancreatic cancer	0.0213	0.0302	CbGbCtD
Glyburide—ABCC1—Docetaxel—pancreatic cancer	0.0211	0.0299	CbGbCtD
Glyburide—ABCG2—Irinotecan—pancreatic cancer	0.0192	0.0273	CbGbCtD
Glyburide—ABCG2—Fluorouracil—pancreatic cancer	0.0185	0.0262	CbGbCtD
Glyburide—ABCC1—Doxorubicin—pancreatic cancer	0.0157	0.0223	CbGbCtD
Glyburide—ABCC2—Docetaxel—pancreatic cancer	0.0156	0.0221	CbGbCtD
Glyburide—ABCC2—Sunitinib—pancreatic cancer	0.0155	0.022	CbGbCtD
Glyburide—ALB—Erlotinib—pancreatic cancer	0.0147	0.0208	CbGbCtD
Glyburide—ABCG2—Docetaxel—pancreatic cancer	0.0141	0.02	CbGbCtD
Glyburide—ABCG2—Sunitinib—pancreatic cancer	0.014	0.0199	CbGbCtD
Glyburide—ALB—Irinotecan—pancreatic cancer	0.0133	0.0188	CbGbCtD
Glyburide—ALB—Fluorouracil—pancreatic cancer	0.0127	0.0181	CbGbCtD
Glyburide—ABCB11—bile duct—pancreatic cancer	0.012	0.129	CbGeAlD
Glyburide—ABCC2—Doxorubicin—pancreatic cancer	0.0116	0.0165	CbGbCtD
Glyburide—CYP2C19—Tamoxifen—pancreatic cancer	0.0112	0.0159	CbGbCtD
Glyburide—ABCG2—Doxorubicin—pancreatic cancer	0.0105	0.0149	CbGbCtD
Glyburide—CYP2C9—Tamoxifen—pancreatic cancer	0.00931	0.0132	CbGbCtD
Glyburide—ABCB11—bile—pancreatic cancer	0.00925	0.0993	CbGeAlD
Glyburide—ABCB1—Tamoxifen—pancreatic cancer	0.00903	0.0128	CbGbCtD
Glyburide—ABCB1—Gemcitabine—pancreatic cancer	0.00778	0.011	CbGbCtD
Glyburide—ABCB1—Erlotinib—pancreatic cancer	0.00768	0.0109	CbGbCtD
Glyburide—ABCC3—bile duct—pancreatic cancer	0.00766	0.0823	CbGeAlD
Glyburide—ABCB1—Irinotecan—pancreatic cancer	0.00694	0.00985	CbGbCtD
Glyburide—CYP2C9—Fluorouracil—pancreatic cancer	0.00686	0.00974	CbGbCtD
Glyburide—ABCC2—bile duct—pancreatic cancer	0.00612	0.0657	CbGeAlD
Glyburide—CYP3A4—Tamoxifen—pancreatic cancer	0.00541	0.00768	CbGbCtD
Glyburide—ABCB1—Docetaxel—pancreatic cancer	0.00508	0.00722	CbGbCtD
Glyburide—ABCB1—Sunitinib—pancreatic cancer	0.00506	0.00718	CbGbCtD
Glyburide—ABCC2—bile—pancreatic cancer	0.0047	0.0505	CbGeAlD
Glyburide—CYP3A4—Erlotinib—pancreatic cancer	0.0046	0.00653	CbGbCtD
Glyburide—CYP3A4—Irinotecan—pancreatic cancer	0.00416	0.0059	CbGbCtD
Glyburide—ABCB1—Doxorubicin—pancreatic cancer	0.00379	0.00538	CbGbCtD
Glyburide—CFTR—gall bladder—pancreatic cancer	0.00313	0.0336	CbGeAlD
Glyburide—CYP3A4—Docetaxel—pancreatic cancer	0.00305	0.00432	CbGbCtD
Glyburide—CYP3A4—Sunitinib—pancreatic cancer	0.00303	0.0043	CbGbCtD
Glyburide—KCNJ5—pancreas—pancreatic cancer	0.00297	0.0319	CbGeAlD
Glyburide—CPT1A—islet of Langerhans—pancreatic cancer	0.00233	0.025	CbGeAlD
Glyburide—CYP3A4—Doxorubicin—pancreatic cancer	0.00227	0.00322	CbGbCtD
Glyburide—CFTR—islet of Langerhans—pancreatic cancer	0.00205	0.022	CbGeAlD
Glyburide—CPT1A—pancreas—pancreatic cancer	0.00164	0.0176	CbGeAlD
Glyburide—ABCC3—gall bladder—pancreatic cancer	0.00163	0.0175	CbGeAlD
Glyburide—CFTR—pancreas—pancreatic cancer	0.00144	0.0155	CbGeAlD
Glyburide—CPT1A—digestive system—pancreatic cancer	0.0014	0.015	CbGeAlD
Glyburide—ALB—gall bladder—pancreatic cancer	0.00139	0.015	CbGeAlD
Glyburide—KCNJ11—islet of Langerhans—pancreatic cancer	0.00138	0.0149	CbGeAlD
Glyburide—Gliclazide—VEGFA—pancreatic cancer	0.0013	0.429	CrCbGaD
Glyburide—ABCA1—digestive system—pancreatic cancer	0.0013	0.014	CbGeAlD
Glyburide—ABCC8—islet of Langerhans—pancreatic cancer	0.00128	0.0137	CbGeAlD
Glyburide—CFTR—digestive system—pancreatic cancer	0.00123	0.0132	CbGeAlD
Glyburide—ABCB11—digestive system—pancreatic cancer	0.00101	0.0109	CbGeAlD
Glyburide—Glipizide—PPARG—pancreatic cancer	0.001	0.33	CrCbGaD
Glyburide—KCNJ11—pancreas—pancreatic cancer	0.000974	0.0105	CbGeAlD
Glyburide—SLC22A7—digestive system—pancreatic cancer	0.000911	0.00979	CbGeAlD
Glyburide—ABCC8—pancreas—pancreatic cancer	0.000897	0.00963	CbGeAlD
Glyburide—SLC15A1—digestive system—pancreatic cancer	0.000732	0.00786	CbGeAlD
Glyburide—Bezafibrate—PPARG—pancreatic cancer	0.000732	0.241	CrCbGaD
Glyburide—ABCC3—digestive system—pancreatic cancer	0.000643	0.00691	CbGeAlD
Glyburide—SLCO2B1—digestive system—pancreatic cancer	0.000599	0.00644	CbGeAlD
Glyburide—SLCO1A2—digestive system—pancreatic cancer	0.000552	0.00592	CbGeAlD
Glyburide—ABCC2—digestive system—pancreatic cancer	0.000514	0.00552	CbGeAlD
Glyburide—CYP2C19—digestive system—pancreatic cancer	0.000442	0.00474	CbGeAlD
Glyburide—CYP2C9—digestive system—pancreatic cancer	0.000342	0.00368	CbGeAlD
Glyburide—ABCB1—islet of Langerhans—pancreatic cancer	0.000308	0.00331	CbGeAlD
Glyburide—CYP3A4—digestive system—pancreatic cancer	0.000261	0.0028	CbGeAlD
Glyburide—Vascular purpura—Epirubicin—pancreatic cancer	0.000238	0.00189	CcSEcCtD
Glyburide—Jaundice—Docetaxel—pancreatic cancer	0.000238	0.00188	CcSEcCtD
Glyburide—Hepatic failure—Epirubicin—pancreatic cancer	0.000237	0.00188	CcSEcCtD
Glyburide—Decreased appetite—Sunitinib—pancreatic cancer	0.000237	0.00188	CcSEcCtD
Glyburide—Leukopenia—Fluorouracil—pancreatic cancer	0.000236	0.00187	CcSEcCtD
Glyburide—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000236	0.00186	CcSEcCtD
Glyburide—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000235	0.00186	CcSEcCtD
Glyburide—Renal failure acute—Epirubicin—pancreatic cancer	0.000231	0.00183	CcSEcCtD
Glyburide—Asthenia—Tamoxifen—pancreatic cancer	0.000229	0.00181	CcSEcCtD
Glyburide—Convulsion—Fluorouracil—pancreatic cancer	0.000229	0.00181	CcSEcCtD
Glyburide—Arthralgia—Gemcitabine—pancreatic cancer	0.000229	0.00181	CcSEcCtD
Glyburide—Myalgia—Gemcitabine—pancreatic cancer	0.000229	0.00181	CcSEcCtD
Glyburide—Agranulocytosis—Docetaxel—pancreatic cancer	0.000227	0.0018	CcSEcCtD
Glyburide—Confusional state—Irinotecan—pancreatic cancer	0.000227	0.00179	CcSEcCtD
Glyburide—Asthenia—Erlotinib—pancreatic cancer	0.000226	0.00179	CcSEcCtD
Glyburide—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000226	0.00179	CcSEcCtD
Glyburide—Pruritus—Tamoxifen—pancreatic cancer	0.000226	0.00178	CcSEcCtD
Glyburide—Oedema—Irinotecan—pancreatic cancer	0.000225	0.00178	CcSEcCtD
Glyburide—Myalgia—Fluorouracil—pancreatic cancer	0.000225	0.00178	CcSEcCtD
Glyburide—Renal impairment—Epirubicin—pancreatic cancer	0.000224	0.00177	CcSEcCtD
Glyburide—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000223	0.00176	CcSEcCtD
Glyburide—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000223	0.00176	CcSEcCtD
Glyburide—Pruritus—Erlotinib—pancreatic cancer	0.000223	0.00176	CcSEcCtD
Glyburide—Purpura—Epirubicin—pancreatic cancer	0.000221	0.00175	CcSEcCtD
Glyburide—Shock—Irinotecan—pancreatic cancer	0.000221	0.00175	CcSEcCtD
Glyburide—Vascular purpura—Doxorubicin—pancreatic cancer	0.000221	0.00174	CcSEcCtD
Glyburide—Nervous system disorder—Irinotecan—pancreatic cancer	0.000221	0.00174	CcSEcCtD
Glyburide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00022	0.00174	CcSEcCtD
Glyburide—Hepatic failure—Doxorubicin—pancreatic cancer	0.00022	0.00174	CcSEcCtD
Glyburide—Oedema—Gemcitabine—pancreatic cancer	0.000219	0.00173	CcSEcCtD
Glyburide—Hepatitis—Docetaxel—pancreatic cancer	0.000219	0.00173	CcSEcCtD
Glyburide—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000219	0.00173	CcSEcCtD
Glyburide—Diarrhoea—Tamoxifen—pancreatic cancer	0.000218	0.00172	CcSEcCtD
Glyburide—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000217	0.00172	CcSEcCtD
Glyburide—Confusional state—Fluorouracil—pancreatic cancer	0.000217	0.00172	CcSEcCtD
Glyburide—ABCB1—pancreas—pancreatic cancer	0.000216	0.00232	CbGeAlD
Glyburide—Abdominal pain—Sunitinib—pancreatic cancer	0.000216	0.00171	CcSEcCtD
Glyburide—Diarrhoea—Erlotinib—pancreatic cancer	0.000216	0.00171	CcSEcCtD
Glyburide—Oedema—Fluorouracil—pancreatic cancer	0.000215	0.0017	CcSEcCtD
Glyburide—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000215	0.0017	CcSEcCtD
Glyburide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000214	0.0017	CcSEcCtD
Glyburide—Anorexia—Irinotecan—pancreatic cancer	0.000214	0.00169	CcSEcCtD
Glyburide—Hyponatraemia—Epirubicin—pancreatic cancer	0.000214	0.00169	CcSEcCtD
Glyburide—Renal failure acute—Doxorubicin—pancreatic cancer	0.000214	0.00169	CcSEcCtD
Glyburide—Diplopia—Epirubicin—pancreatic cancer	0.000213	0.00169	CcSEcCtD
Glyburide—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000212	0.00167	CcSEcCtD
Glyburide—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000211	0.00167	CcSEcCtD
Glyburide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000211	0.00167	CcSEcCtD
Glyburide—Visual impairment—Docetaxel—pancreatic cancer	0.000211	0.00167	CcSEcCtD
Glyburide—Hypotension—Irinotecan—pancreatic cancer	0.00021	0.00166	CcSEcCtD
Glyburide—Anorexia—Gemcitabine—pancreatic cancer	0.000209	0.00165	CcSEcCtD
Glyburide—Renal impairment—Doxorubicin—pancreatic cancer	0.000207	0.00164	CcSEcCtD
Glyburide—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000207	0.00163	CcSEcCtD
Glyburide—Anorexia—Fluorouracil—pancreatic cancer	0.000205	0.00162	CcSEcCtD
Glyburide—Purpura—Doxorubicin—pancreatic cancer	0.000205	0.00162	CcSEcCtD
Glyburide—Hypotension—Gemcitabine—pancreatic cancer	0.000205	0.00162	CcSEcCtD
Glyburide—Eye disorder—Docetaxel—pancreatic cancer	0.000204	0.00162	CcSEcCtD
Glyburide—Vomiting—Tamoxifen—pancreatic cancer	0.000203	0.0016	CcSEcCtD
Glyburide—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000202	0.0016	CcSEcCtD
Glyburide—Paraesthesia—Irinotecan—pancreatic cancer	0.000202	0.0016	CcSEcCtD
Glyburide—Hypotension—Fluorouracil—pancreatic cancer	0.000201	0.00159	CcSEcCtD
Glyburide—Hypersensitivity—Sunitinib—pancreatic cancer	0.000201	0.00159	CcSEcCtD
Glyburide—Rash—Tamoxifen—pancreatic cancer	0.000201	0.00159	CcSEcCtD
Glyburide—Dermatitis—Tamoxifen—pancreatic cancer	0.000201	0.00159	CcSEcCtD
Glyburide—Vomiting—Erlotinib—pancreatic cancer	0.000201	0.00159	CcSEcCtD
Glyburide—Dyspnoea—Irinotecan—pancreatic cancer	0.0002	0.00158	CcSEcCtD
Glyburide—Headache—Tamoxifen—pancreatic cancer	0.0002	0.00158	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.0002	0.00158	CcSEcCtD
Glyburide—Rash—Erlotinib—pancreatic cancer	0.000199	0.00157	CcSEcCtD
Glyburide—Dermatitis—Erlotinib—pancreatic cancer	0.000199	0.00157	CcSEcCtD
Glyburide—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000198	0.00157	CcSEcCtD
Glyburide—Dyspepsia—Irinotecan—pancreatic cancer	0.000198	0.00156	CcSEcCtD
Glyburide—Headache—Erlotinib—pancreatic cancer	0.000198	0.00156	CcSEcCtD
Glyburide—Diplopia—Doxorubicin—pancreatic cancer	0.000197	0.00156	CcSEcCtD
Glyburide—Paraesthesia—Gemcitabine—pancreatic cancer	0.000197	0.00155	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000196	0.00155	CcSEcCtD
Glyburide—Asthenia—Sunitinib—pancreatic cancer	0.000196	0.00155	CcSEcCtD
Glyburide—Decreased appetite—Irinotecan—pancreatic cancer	0.000195	0.00155	CcSEcCtD
Glyburide—Dyspnoea—Gemcitabine—pancreatic cancer	0.000195	0.00154	CcSEcCtD
Glyburide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000194	0.00153	CcSEcCtD
Glyburide—Paraesthesia—Fluorouracil—pancreatic cancer	0.000193	0.00153	CcSEcCtD
Glyburide—Alopecia—Docetaxel—pancreatic cancer	0.000193	0.00153	CcSEcCtD
Glyburide—Pruritus—Sunitinib—pancreatic cancer	0.000193	0.00153	CcSEcCtD
Glyburide—Dyspnoea—Fluorouracil—pancreatic cancer	0.000192	0.00152	CcSEcCtD
Glyburide—Malnutrition—Docetaxel—pancreatic cancer	0.00019	0.00151	CcSEcCtD
Glyburide—Erythema—Docetaxel—pancreatic cancer	0.00019	0.00151	CcSEcCtD
Glyburide—Decreased appetite—Gemcitabine—pancreatic cancer	0.00019	0.00151	CcSEcCtD
Glyburide—Dyspepsia—Fluorouracil—pancreatic cancer	0.00019	0.0015	CcSEcCtD
Glyburide—Nausea—Tamoxifen—pancreatic cancer	0.000189	0.0015	CcSEcCtD
Glyburide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000189	0.00149	CcSEcCtD
Glyburide—Nausea—Erlotinib—pancreatic cancer	0.000187	0.00148	CcSEcCtD
Glyburide—Decreased appetite—Fluorouracil—pancreatic cancer	0.000187	0.00148	CcSEcCtD
Glyburide—Diarrhoea—Sunitinib—pancreatic cancer	0.000187	0.00148	CcSEcCtD
Glyburide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000186	0.00147	CcSEcCtD
Glyburide—Abdominal distension—Epirubicin—pancreatic cancer	0.000186	0.00147	CcSEcCtD
Glyburide—Feeling abnormal—Irinotecan—pancreatic cancer	0.000185	0.00146	CcSEcCtD
Glyburide—ABCB1—digestive system—pancreatic cancer	0.000185	0.00198	CbGeAlD
Glyburide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000184	0.00145	CcSEcCtD
Glyburide—Eosinophilia—Epirubicin—pancreatic cancer	0.000183	0.00144	CcSEcCtD
Glyburide—Pancreatitis—Epirubicin—pancreatic cancer	0.000181	0.00143	CcSEcCtD
Glyburide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000181	0.00143	CcSEcCtD
Glyburide—Abdominal pain—Irinotecan—pancreatic cancer	0.000178	0.00141	CcSEcCtD
Glyburide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000177	0.0014	CcSEcCtD
Glyburide—Anaemia—Docetaxel—pancreatic cancer	0.000176	0.00139	CcSEcCtD
Glyburide—Pancytopenia—Epirubicin—pancreatic cancer	0.000175	0.00138	CcSEcCtD
Glyburide—Vomiting—Sunitinib—pancreatic cancer	0.000174	0.00137	CcSEcCtD
Glyburide—Rash—Sunitinib—pancreatic cancer	0.000172	0.00136	CcSEcCtD
Glyburide—Dermatitis—Sunitinib—pancreatic cancer	0.000172	0.00136	CcSEcCtD
Glyburide—Abdominal distension—Doxorubicin—pancreatic cancer	0.000172	0.00136	CcSEcCtD
Glyburide—Urticaria—Fluorouracil—pancreatic cancer	0.000171	0.00135	CcSEcCtD
Glyburide—Headache—Sunitinib—pancreatic cancer	0.000171	0.00135	CcSEcCtD
Glyburide—Leukopenia—Docetaxel—pancreatic cancer	0.000171	0.00135	CcSEcCtD
Glyburide—Eosinophilia—Doxorubicin—pancreatic cancer	0.000169	0.00134	CcSEcCtD
Glyburide—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000168	0.00133	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—pancreatic cancer	0.000167	0.00132	CcSEcCtD
Glyburide—Hypersensitivity—Irinotecan—pancreatic cancer	0.000166	0.00131	CcSEcCtD
Glyburide—Convulsion—Docetaxel—pancreatic cancer	0.000165	0.0013	CcSEcCtD
Glyburide—Arthralgia—Docetaxel—pancreatic cancer	0.000162	0.00128	CcSEcCtD
Glyburide—Myalgia—Docetaxel—pancreatic cancer	0.000162	0.00128	CcSEcCtD
Glyburide—Nausea—Sunitinib—pancreatic cancer	0.000162	0.00128	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—pancreatic cancer	0.000162	0.00128	CcSEcCtD
Glyburide—Asthenia—Irinotecan—pancreatic cancer	0.000161	0.00128	CcSEcCtD
Glyburide—Jaundice—Epirubicin—pancreatic cancer	0.00016	0.00127	CcSEcCtD
Glyburide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000159	0.00125	CcSEcCtD
Glyburide—Asthenia—Gemcitabine—pancreatic cancer	0.000157	0.00124	CcSEcCtD
Glyburide—Confusional state—Docetaxel—pancreatic cancer	0.000157	0.00124	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000156	0.00123	CcSEcCtD
Glyburide—Oedema—Docetaxel—pancreatic cancer	0.000155	0.00123	CcSEcCtD
Glyburide—Pruritus—Gemcitabine—pancreatic cancer	0.000155	0.00123	CcSEcCtD
Glyburide—Diarrhoea—Irinotecan—pancreatic cancer	0.000154	0.00122	CcSEcCtD
Glyburide—Agranulocytosis—Epirubicin—pancreatic cancer	0.000153	0.00121	CcSEcCtD
Glyburide—Shock—Docetaxel—pancreatic cancer	0.000153	0.00121	CcSEcCtD
Glyburide—Nervous system disorder—Docetaxel—pancreatic cancer	0.000152	0.00121	CcSEcCtD
Glyburide—Pruritus—Fluorouracil—pancreatic cancer	0.000152	0.0012	CcSEcCtD
Glyburide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000152	0.0012	CcSEcCtD
Glyburide—Diarrhoea—Gemcitabine—pancreatic cancer	0.00015	0.00118	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—pancreatic cancer	0.000148	0.00117	CcSEcCtD
Glyburide—Anorexia—Docetaxel—pancreatic cancer	0.000148	0.00117	CcSEcCtD
Glyburide—Hepatitis—Epirubicin—pancreatic cancer	0.000148	0.00117	CcSEcCtD
Glyburide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000147	0.00116	CcSEcCtD
Glyburide—Hypotension—Docetaxel—pancreatic cancer	0.000145	0.00115	CcSEcCtD
Glyburide—Vomiting—Irinotecan—pancreatic cancer	0.000143	0.00113	CcSEcCtD
Glyburide—Visual impairment—Epirubicin—pancreatic cancer	0.000142	0.00112	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000142	0.00112	CcSEcCtD
Glyburide—Rash—Irinotecan—pancreatic cancer	0.000142	0.00112	CcSEcCtD
Glyburide—Dermatitis—Irinotecan—pancreatic cancer	0.000142	0.00112	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000142	0.00112	CcSEcCtD
Glyburide—Headache—Irinotecan—pancreatic cancer	0.000141	0.00111	CcSEcCtD
Glyburide—Paraesthesia—Docetaxel—pancreatic cancer	0.00014	0.0011	CcSEcCtD
Glyburide—Vomiting—Gemcitabine—pancreatic cancer	0.000139	0.0011	CcSEcCtD
Glyburide—Dyspnoea—Docetaxel—pancreatic cancer	0.000139	0.0011	CcSEcCtD
Glyburide—Rash—Gemcitabine—pancreatic cancer	0.000138	0.00109	CcSEcCtD
Glyburide—Dermatitis—Gemcitabine—pancreatic cancer	0.000138	0.00109	CcSEcCtD
Glyburide—Eye disorder—Epirubicin—pancreatic cancer	0.000138	0.00109	CcSEcCtD
Glyburide—Headache—Gemcitabine—pancreatic cancer	0.000137	0.00108	CcSEcCtD
Glyburide—Vomiting—Fluorouracil—pancreatic cancer	0.000137	0.00108	CcSEcCtD
Glyburide—Dyspepsia—Docetaxel—pancreatic cancer	0.000137	0.00108	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—pancreatic cancer	0.000137	0.00108	CcSEcCtD
Glyburide—Rash—Fluorouracil—pancreatic cancer	0.000136	0.00107	CcSEcCtD
Glyburide—Dermatitis—Fluorouracil—pancreatic cancer	0.000136	0.00107	CcSEcCtD
Glyburide—Decreased appetite—Docetaxel—pancreatic cancer	0.000135	0.00107	CcSEcCtD
Glyburide—Headache—Fluorouracil—pancreatic cancer	0.000135	0.00107	CcSEcCtD
Glyburide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000134	0.00106	CcSEcCtD
Glyburide—Nausea—Irinotecan—pancreatic cancer	0.000134	0.00106	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—pancreatic cancer	0.000132	0.00104	CcSEcCtD
Glyburide—Alopecia—Epirubicin—pancreatic cancer	0.00013	0.00103	CcSEcCtD
Glyburide—Nausea—Gemcitabine—pancreatic cancer	0.00013	0.00103	CcSEcCtD
Glyburide—Malnutrition—Epirubicin—pancreatic cancer	0.000128	0.00102	CcSEcCtD
Glyburide—Erythema—Epirubicin—pancreatic cancer	0.000128	0.00102	CcSEcCtD
Glyburide—Feeling abnormal—Docetaxel—pancreatic cancer	0.000128	0.00101	CcSEcCtD
Glyburide—Nausea—Fluorouracil—pancreatic cancer	0.000128	0.00101	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—pancreatic cancer	0.000128	0.00101	CcSEcCtD
Glyburide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000127	0.001	CcSEcCtD
Glyburide—Abdominal pain—Docetaxel—pancreatic cancer	0.000123	0.000971	CcSEcCtD
Glyburide—Vision blurred—Epirubicin—pancreatic cancer	0.000121	0.000957	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—pancreatic cancer	0.000121	0.000954	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—pancreatic cancer	0.000119	0.00094	CcSEcCtD
Glyburide—Erythema—Doxorubicin—pancreatic cancer	0.000119	0.00094	CcSEcCtD
Glyburide—Anaemia—Epirubicin—pancreatic cancer	0.000119	0.000939	CcSEcCtD
Glyburide—Leukopenia—Epirubicin—pancreatic cancer	0.000115	0.000909	CcSEcCtD
Glyburide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000115	0.000905	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—pancreatic cancer	0.000112	0.000886	CcSEcCtD
Glyburide—Asthenia—Docetaxel—pancreatic cancer	0.000112	0.000882	CcSEcCtD
Glyburide—Convulsion—Epirubicin—pancreatic cancer	0.000111	0.00088	CcSEcCtD
Glyburide—Pruritus—Docetaxel—pancreatic cancer	0.00011	0.000869	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—pancreatic cancer	0.00011	0.000869	CcSEcCtD
Glyburide—Arthralgia—Epirubicin—pancreatic cancer	0.000109	0.000865	CcSEcCtD
Glyburide—Myalgia—Epirubicin—pancreatic cancer	0.000109	0.000865	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—pancreatic cancer	0.000106	0.000841	CcSEcCtD
Glyburide—Diarrhoea—Docetaxel—pancreatic cancer	0.000106	0.000841	CcSEcCtD
Glyburide—Confusional state—Epirubicin—pancreatic cancer	0.000106	0.000836	CcSEcCtD
Glyburide—Oedema—Epirubicin—pancreatic cancer	0.000105	0.000829	CcSEcCtD
Glyburide—Shock—Epirubicin—pancreatic cancer	0.000103	0.000815	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—pancreatic cancer	0.000103	0.000814	CcSEcCtD
Glyburide—Nervous system disorder—Epirubicin—pancreatic cancer	0.000103	0.000813	CcSEcCtD
Glyburide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000103	0.000812	CcSEcCtD
Glyburide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000101	0.000801	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—pancreatic cancer	0.000101	0.0008	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—pancreatic cancer	0.000101	0.0008	CcSEcCtD
Glyburide—Anorexia—Epirubicin—pancreatic cancer	0.0001	0.00079	CcSEcCtD
Glyburide—Vomiting—Docetaxel—pancreatic cancer	9.88e-05	0.000781	CcSEcCtD
Glyburide—Rash—Docetaxel—pancreatic cancer	9.8e-05	0.000775	CcSEcCtD
Glyburide—Hypotension—Epirubicin—pancreatic cancer	9.8e-05	0.000774	CcSEcCtD
Glyburide—Dermatitis—Docetaxel—pancreatic cancer	9.79e-05	0.000774	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—pancreatic cancer	9.78e-05	0.000773	CcSEcCtD
Glyburide—Headache—Docetaxel—pancreatic cancer	9.74e-05	0.00077	CcSEcCtD
Glyburide—Oedema—Doxorubicin—pancreatic cancer	9.7e-05	0.000767	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	9.55e-05	0.000755	CcSEcCtD
Glyburide—Shock—Doxorubicin—pancreatic cancer	9.55e-05	0.000755	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—pancreatic cancer	9.51e-05	0.000752	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—pancreatic cancer	9.5e-05	0.000751	CcSEcCtD
Glyburide—Paraesthesia—Epirubicin—pancreatic cancer	9.42e-05	0.000744	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—pancreatic cancer	9.38e-05	0.000741	CcSEcCtD
Glyburide—Dyspnoea—Epirubicin—pancreatic cancer	9.35e-05	0.000739	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—pancreatic cancer	9.25e-05	0.000731	CcSEcCtD
Glyburide—Nausea—Docetaxel—pancreatic cancer	9.23e-05	0.00073	CcSEcCtD
Glyburide—Dyspepsia—Epirubicin—pancreatic cancer	9.23e-05	0.00073	CcSEcCtD
Glyburide—Decreased appetite—Epirubicin—pancreatic cancer	9.12e-05	0.000721	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—pancreatic cancer	9.07e-05	0.000717	CcSEcCtD
Glyburide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	9.05e-05	0.000716	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	8.84e-05	0.000699	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—pancreatic cancer	8.71e-05	0.000689	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—pancreatic cancer	8.65e-05	0.000684	CcSEcCtD
Glyburide—Feeling abnormal—Epirubicin—pancreatic cancer	8.64e-05	0.000683	CcSEcCtD
Glyburide—Gastrointestinal pain—Epirubicin—pancreatic cancer	8.57e-05	0.000678	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—pancreatic cancer	8.54e-05	0.000675	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—pancreatic cancer	8.43e-05	0.000667	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	8.38e-05	0.000662	CcSEcCtD
Glyburide—Urticaria—Epirubicin—pancreatic cancer	8.33e-05	0.000658	CcSEcCtD
Glyburide—Abdominal pain—Epirubicin—pancreatic cancer	8.29e-05	0.000655	CcSEcCtD
Glyburide—Feeling abnormal—Doxorubicin—pancreatic cancer	8e-05	0.000632	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	7.93e-05	0.000627	CcSEcCtD
Glyburide—Hypersensitivity—Epirubicin—pancreatic cancer	7.73e-05	0.000611	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—pancreatic cancer	7.71e-05	0.000609	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—pancreatic cancer	7.67e-05	0.000606	CcSEcCtD
Glyburide—Asthenia—Epirubicin—pancreatic cancer	7.52e-05	0.000595	CcSEcCtD
Glyburide—Pruritus—Epirubicin—pancreatic cancer	7.42e-05	0.000586	CcSEcCtD
Glyburide—Diarrhoea—Epirubicin—pancreatic cancer	7.17e-05	0.000567	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—pancreatic cancer	7.15e-05	0.000565	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—pancreatic cancer	6.96e-05	0.00055	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—pancreatic cancer	6.86e-05	0.000543	CcSEcCtD
Glyburide—Vomiting—Epirubicin—pancreatic cancer	6.67e-05	0.000527	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—pancreatic cancer	6.64e-05	0.000525	CcSEcCtD
Glyburide—Rash—Epirubicin—pancreatic cancer	6.61e-05	0.000523	CcSEcCtD
Glyburide—Dermatitis—Epirubicin—pancreatic cancer	6.61e-05	0.000522	CcSEcCtD
Glyburide—Headache—Epirubicin—pancreatic cancer	6.57e-05	0.000519	CcSEcCtD
Glyburide—Nausea—Epirubicin—pancreatic cancer	6.23e-05	0.000492	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—pancreatic cancer	6.17e-05	0.000488	CcSEcCtD
Glyburide—Rash—Doxorubicin—pancreatic cancer	6.12e-05	0.000484	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—pancreatic cancer	6.11e-05	0.000483	CcSEcCtD
Glyburide—Headache—Doxorubicin—pancreatic cancer	6.08e-05	0.00048	CcSEcCtD
Glyburide—Nausea—Doxorubicin—pancreatic cancer	5.76e-05	0.000456	CcSEcCtD
Glyburide—ABCC3—Metabolism—TYMS—pancreatic cancer	1.37e-05	0.000187	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.36e-05	0.000187	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.35e-05	0.000186	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.34e-05	0.000184	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.33e-05	0.000183	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GCG—pancreatic cancer	1.32e-05	0.000182	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CG—pancreatic cancer	1.32e-05	0.000182	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ARG2—pancreatic cancer	1.32e-05	0.000181	CbGpPWpGaD
Glyburide—ABCC1—Disease—SMAD4—pancreatic cancer	1.3e-05	0.000179	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.3e-05	0.000178	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ARG2—pancreatic cancer	1.29e-05	0.000177	CbGpPWpGaD
Glyburide—ALB—Metabolism—TYMP—pancreatic cancer	1.29e-05	0.000177	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CG—pancreatic cancer	1.28e-05	0.000176	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PPARG—pancreatic cancer	1.28e-05	0.000175	CbGpPWpGaD
Glyburide—ABCC1—Disease—HES1—pancreatic cancer	1.27e-05	0.000174	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	1.25e-05	0.000172	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—STK11—pancreatic cancer	1.24e-05	0.000171	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PPARG—pancreatic cancer	1.24e-05	0.00017	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.23e-05	0.000169	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	1.22e-05	0.000168	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CD44—pancreatic cancer	1.21e-05	0.000167	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.2e-05	0.000165	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.2e-05	0.000165	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—TYMS—pancreatic cancer	1.19e-05	0.000163	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PLAU—pancreatic cancer	1.18e-05	0.000162	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.17e-05	0.00016	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GCG—pancreatic cancer	1.16e-05	0.00016	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CD—pancreatic cancer	1.16e-05	0.00016	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—APOE—pancreatic cancer	1.16e-05	0.000159	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.15e-05	0.000158	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CD—pancreatic cancer	1.13e-05	0.000155	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TYMP—pancreatic cancer	1.13e-05	0.000155	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	1.12e-05	0.000154	CbGpPWpGaD
Glyburide—ABCC1—Disease—TERT—pancreatic cancer	1.11e-05	0.000153	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—APOE—pancreatic cancer	1.11e-05	0.000152	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.11e-05	0.000152	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.1e-05	0.000151	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.1e-05	0.000151	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—STK11—pancreatic cancer	1.09e-05	0.00015	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.08e-05	0.000148	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—TYMS—pancreatic cancer	1.07e-05	0.000147	CbGpPWpGaD
Glyburide—ABCC1—Disease—HIF1A—pancreatic cancer	1.06e-05	0.000146	CbGpPWpGaD
Glyburide—ABCC1—Disease—TSC2—pancreatic cancer	1.06e-05	0.000146	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.06e-05	0.000146	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.05e-05	0.000144	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CG—pancreatic cancer	1.05e-05	0.000144	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.05e-05	0.000144	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CG—pancreatic cancer	1.05e-05	0.000144	CbGpPWpGaD
Glyburide—ALB—Hemostasis—EGF—pancreatic cancer	1.04e-05	0.000143	CbGpPWpGaD
Glyburide—ABCC1—Disease—APOE—pancreatic cancer	1.04e-05	0.000143	CbGpPWpGaD
Glyburide—ALB—Metabolism—GLP1R—pancreatic cancer	1.04e-05	0.000142	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.03e-05	0.000141	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.02e-05	0.00014	CbGpPWpGaD
Glyburide—ALB—Metabolism—DPYD—pancreatic cancer	1.02e-05	0.00014	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CB—pancreatic cancer	1.01e-05	0.000139	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PPARG—pancreatic cancer	1.01e-05	0.000139	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTGS2—pancreatic cancer	1e-05	0.000138	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CG—pancreatic cancer	1e-05	0.000138	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PIK3CA—pancreatic cancer	1e-05	0.000137	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PIK3CA—pancreatic cancer	1e-05	0.000137	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CB—pancreatic cancer	9.83e-06	0.000135	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTGS2—pancreatic cancer	9.74e-06	0.000134	CbGpPWpGaD
Glyburide—ALB—Metabolism—SLC2A2—pancreatic cancer	9.67e-06	0.000133	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PPARG—pancreatic cancer	9.67e-06	0.000133	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—APOE—pancreatic cancer	9.67e-06	0.000133	CbGpPWpGaD
Glyburide—ABCC1—Disease—NOTCH1—pancreatic cancer	9.59e-06	0.000132	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.57e-06	0.000131	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	9.53e-06	0.000131	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.52e-06	0.000131	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—TYMS—pancreatic cancer	9.41e-06	0.000129	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	9.38e-06	0.000129	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GLP1R—pancreatic cancer	9.3e-06	0.000128	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGF—pancreatic cancer	9.27e-06	0.000127	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CD—pancreatic cancer	9.24e-06	0.000127	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.24e-06	0.000127	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CD—pancreatic cancer	9.19e-06	0.000126	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PRSS1—pancreatic cancer	9.16e-06	0.000126	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.15e-06	0.000126	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—DPYD—pancreatic cancer	9.15e-06	0.000126	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GLP1R—pancreatic cancer	9.08e-06	0.000125	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	9.08e-06	0.000125	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—DPYD—pancreatic cancer	8.93e-06	0.000123	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CD—pancreatic cancer	8.81e-06	0.000121	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTEN—pancreatic cancer	8.76e-06	0.00012	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	8.73e-06	0.00012	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—APOE—pancreatic cancer	8.7e-06	0.000119	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	8.68e-06	0.000119	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.68e-06	0.000119	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.59e-06	0.000118	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTEN—pancreatic cancer	8.49e-06	0.000117	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GLP1R—pancreatic cancer	8.48e-06	0.000116	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC2A2—pancreatic cancer	8.48e-06	0.000116	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PPARG—pancreatic cancer	8.42e-06	0.000116	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.42e-06	0.000116	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—DPYD—pancreatic cancer	8.34e-06	0.000115	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.29e-06	0.000114	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CD—pancreatic cancer	8.24e-06	0.000113	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.24e-06	0.000113	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AKT1—pancreatic cancer	8.17e-06	0.000112	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AKT1—pancreatic cancer	8.17e-06	0.000112	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CB—pancreatic cancer	8.06e-06	0.000111	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CB—pancreatic cancer	8.01e-06	0.00011	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ARG2—pancreatic cancer	7.94e-06	0.000109	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTGS2—pancreatic cancer	7.94e-06	0.000109	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	7.92e-06	0.000109	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CG—pancreatic cancer	7.85e-06	0.000108	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.84e-06	0.000108	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	7.78e-06	0.000107	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CB—pancreatic cancer	7.68e-06	0.000105	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	7.67e-06	0.000105	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	7.67e-06	0.000105	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—APOE—pancreatic cancer	7.66e-06	0.000105	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTGS2—pancreatic cancer	7.61e-06	0.000104	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PPARG—pancreatic cancer	7.58e-06	0.000104	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.56e-06	0.000104	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.55e-06	0.000104	CbGpPWpGaD
Glyburide—ALB—Metabolism—CD44—pancreatic cancer	7.49e-06	0.000103	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.34e-06	0.000101	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.27e-06	9.98e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CB—pancreatic cancer	7.18e-06	9.87e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GCG—pancreatic cancer	7.18e-06	9.86e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTGS2—pancreatic cancer	7.12e-06	9.78e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TYMP—pancreatic cancer	6.94e-06	9.53e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTEN—pancreatic cancer	6.92e-06	9.5e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CG—pancreatic cancer	6.91e-06	9.49e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CD—pancreatic cancer	6.9e-06	9.48e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.89e-06	9.46e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—STK11—pancreatic cancer	6.75e-06	9.27e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CD44—pancreatic cancer	6.73e-06	9.24e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	6.69e-06	9.18e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PPARG—pancreatic cancer	6.67e-06	9.16e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTEN—pancreatic cancer	6.64e-06	9.11e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	6.63e-06	9.1e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.59e-06	9.04e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CD44—pancreatic cancer	6.56e-06	9.01e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.52e-06	8.96e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SRC—pancreatic cancer	6.46e-06	8.87e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GCG—pancreatic cancer	6.45e-06	8.85e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CTNNB1—pancreatic cancer	6.37e-06	8.75e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.34e-06	8.7e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GCG—pancreatic cancer	6.29e-06	8.64e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—pancreatic cancer	6.29e-06	8.64e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—NRAS—pancreatic cancer	6.21e-06	8.53e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTEN—pancreatic cancer	6.21e-06	8.53e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CA—pancreatic cancer	6.18e-06	8.48e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CD44—pancreatic cancer	6.13e-06	8.42e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CD—pancreatic cancer	6.07e-06	8.34e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—STK11—pancreatic cancer	6.06e-06	8.32e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CB—pancreatic cancer	6.02e-06	8.26e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6e-06	8.25e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CA—pancreatic cancer	5.99e-06	8.22e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTGS2—pancreatic cancer	5.96e-06	8.19e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.95e-06	8.17e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—STK11—pancreatic cancer	5.92e-06	8.13e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GCG—pancreatic cancer	5.88e-06	8.07e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—TYMS—pancreatic cancer	5.81e-06	7.98e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTEN—pancreatic cancer	5.78e-06	7.93e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TGFB1—pancreatic cancer	5.77e-06	7.93e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—SRC—pancreatic cancer	5.76e-06	7.91e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.69e-06	7.81e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GLP1R—pancreatic cancer	5.59e-06	7.68e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—STAT3—pancreatic cancer	5.55e-06	7.62e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—NRAS—pancreatic cancer	5.54e-06	7.61e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—STK11—pancreatic cancer	5.53e-06	7.59e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—DPYD—pancreatic cancer	5.5e-06	7.56e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—pancreatic cancer	5.35e-06	7.34e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CB—pancreatic cancer	5.29e-06	7.27e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS2—pancreatic cancer	5.25e-06	7.2e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	5.22e-06	7.17e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TYMS—pancreatic cancer	5.21e-06	7.16e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTEN—pancreatic cancer	5.2e-06	7.14e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.19e-06	7.13e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—pancreatic cancer	5.16e-06	7.08e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—TGFB1—pancreatic cancer	5.15e-06	7.07e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TYMS—pancreatic cancer	5.09e-06	6.99e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—pancreatic cancer	5.05e-06	6.93e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—pancreatic cancer	5.05e-06	6.93e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CA—pancreatic cancer	4.91e-06	6.75e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—pancreatic cancer	4.89e-06	6.72e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CA—pancreatic cancer	4.88e-06	6.7e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—pancreatic cancer	4.77e-06	6.55e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TYMS—pancreatic cancer	4.75e-06	6.53e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—pancreatic cancer	4.75e-06	6.53e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—APOE—pancreatic cancer	4.72e-06	6.49e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CA—pancreatic cancer	4.68e-06	6.43e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTEN—pancreatic cancer	4.57e-06	6.28e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HRAS—pancreatic cancer	4.54e-06	6.24e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.47e-06	6.14e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CA—pancreatic cancer	4.38e-06	6.01e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CG—pancreatic cancer	4.26e-06	5.85e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—APOE—pancreatic cancer	4.24e-06	5.82e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—APOE—pancreatic cancer	4.14e-06	5.68e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARG—pancreatic cancer	4.11e-06	5.65e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	4.08e-06	5.6e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—HRAS—pancreatic cancer	4.05e-06	5.56e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CD44—pancreatic cancer	4.04e-06	5.55e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.01e-06	5.51e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—pancreatic cancer	4.01e-06	5.51e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—pancreatic cancer	3.99e-06	5.48e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GCG—pancreatic cancer	3.88e-06	5.32e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—APOE—pancreatic cancer	3.87e-06	5.31e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	3.83e-06	5.26e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—pancreatic cancer	3.82e-06	5.25e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CD—pancreatic cancer	3.75e-06	5.15e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CG—pancreatic cancer	3.74e-06	5.13e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.69e-06	5.07e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CA—pancreatic cancer	3.67e-06	5.04e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.66e-06	5.03e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—STK11—pancreatic cancer	3.65e-06	5.01e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARG—pancreatic cancer	3.61e-06	4.95e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—pancreatic cancer	3.58e-06	4.91e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3.49e-06	4.79e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.37e-06	4.63e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.36e-06	4.62e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—pancreatic cancer	3.33e-06	4.57e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.28e-06	4.51e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CB—pancreatic cancer	3.27e-06	4.49e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS2—pancreatic cancer	3.24e-06	4.45e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CA—pancreatic cancer	3.23e-06	4.43e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.14e-06	4.31e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.07e-06	4.21e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—pancreatic cancer	3e-06	4.11e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.93e-06	4.03e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.91e-06	3.99e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.86e-06	3.93e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.84e-06	3.89e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTEN—pancreatic cancer	2.82e-06	3.88e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.67e-06	3.67e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.65e-06	3.64e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—pancreatic cancer	2.64e-06	3.62e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—APOE—pancreatic cancer	2.55e-06	3.5e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.53e-06	3.48e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTEN—pancreatic cancer	2.47e-06	3.4e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.31e-06	3.17e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.3e-06	3.16e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.22e-06	3.05e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.02e-06	2.78e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CA—pancreatic cancer	1.99e-06	2.73e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.79e-06	2.46e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.76e-06	2.42e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.75e-06	2.4e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.74e-06	2.4e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.63e-06	2.24e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—pancreatic cancer	1.63e-06	2.23e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.52e-06	2.09e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.46e-06	2.01e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—pancreatic cancer	1.43e-06	1.96e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.33e-06	1.83e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.08e-06	1.48e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—pancreatic cancer	8.78e-07	1.21e-05	CbGpPWpGaD
